Order Article Reprints

Gralewska P, Gajek A, Marczak A, Mikuła M, Ostrowski J, Śliwińska A, Rogalska A. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. International Journal of Molecular Sciences. 2020; 21(24):9715. https://doi.org/10.3390/ijms21249715

Gralewska, Patrycja, Arkadiusz Gajek, Agnieszka Marczak, Michał Mikuła, Jerzy Ostrowski, Agnieszka Śliwińska, and Aneta Rogalska. 2020. "PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness" International Journal of Molecular Sciences 21, no. 24: 9715. https://doi.org/10.3390/ijms21249715

Gralewska, P., Gajek, A., Marczak, A., Mikuła, M., Ostrowski, J., Śliwińska, A., & Rogalska, A. (2020). PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. International Journal of Molecular Sciences, 21(24), 9715. https://doi.org/10.3390/ijms21249715